相关实验视频

Updated: Jul 4, 2025

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction

Published on: January 22, 2020

卡利科辛增强了Treg分化,以缓解在亚托皮炎中的皮肤炎症

Xin Ma¹, Guoshu Deng², Na Tian³

¹Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China; Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China.

Journal of ethnopharmacology

|February 8, 2024

概括

卡利科辛 (CA) 通过促进调控性T细胞 (Treg) 分化和抑制T辅助者17 (Th17) 细胞分化,有效地治疗皮炎 (AD),提供了一个新的治疗选择.

科学领域:

免疫学免疫学免疫学
皮肤病学皮肤病学
药理学药理学是指药理学的学科.

背景情况:

亚托皮炎 (AD) 是一种广泛的炎症性皮肤疾病,治疗选择有限.
,一种传统的中医药,含有卡利科辛 (CA),以抗炎和抗氧化特性而闻名.
在治疗阿尔茨海默症时,AC的确切机制尚未完全理解.

研究的目的:

评估CA在AD治疗中的有效性和安全性.
阐明CA在AD中的作用的基本机制.
研究CA对T细胞分化和炎症通路的影响.

主要方法:

在体外测试 (CCK-8,RT-qPCR) 评估了CA对HaCaT细胞和炎症的影响.
模块化药理学和流细胞计分析了Treg和Th17细胞分化.
一个体内老鼠AD模型 (MC903诱导) 评估了局部CA疗效.
免疫组织化学,RT-qPCR,西斑和ELISA量化了炎症标志物.

主要成果:

在实验室中,CA显示出良好的安全性,并降低了Th2细胞因子表达.
CA促进了Treg分化,并抑制了Th17与原始T细胞的分化.
在体内,CA通过改变关键细胞因子表达 (IL-17A,RORγt,FOXP3) 来改善AD类皮肤病变和调节Treg/Th17平衡.

结论:

在AD中,CA通过调节Treg和Th17细胞分化来发挥抗炎作用.
CA显示了作为阿托皮性皮肤炎管理的替代或辅助疗法的潜力.

关键词:

亚托邦性皮肤炎 (Atopic Dermatitis) 是一种疾病.卡利科辛 (Calycosin) 是一种有氧化物.模块化药理学模块化药理学皮肤炎症皮肤炎症 Th17 这是一个很好的方法.这是Tregs.

更多相关视频

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Published on: April 8, 2016

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Inflammatory Response

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...